Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs ECT in Major Depressive Disorder
NCT02659085Phase 3Completed
- Start
- Feb 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in major depressive disorder (MDD). Started Feb 2015; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02659085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659085.